-
Share
324 Posts.
43
28/01/14
09:27
Share
Towards end of presentation Ed says to the effect that WE see many opportunities in Europe between now and the U.S. launch.
Bring on the U.K. and Europe where we have all relevant approvals while we await FDA approval.
What a wonderful opportunity for a few U.S. and European m-health funds to dip their toes in the water and take a position in Isonea.
A two million dollar investment (5 million shares) per Fund is no big ask & will be forthcoming in the near future.
-